117 related articles for article (PubMed ID: 7558233)
1. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
4. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.
Papapetropoulos A; Abou-Mohamed G; Marczin N; Murad F; Caldwell RW; Catravas JD
Br J Pharmacol; 1996 Jul; 118(6):1359-66. PubMed ID: 8832057
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells.
Papapetropoulos A; Go CY; Murad F; Catravas JD
Br J Pharmacol; 1996 Jan; 117(1):147-55. PubMed ID: 8825356
[TBL] [Abstract][Full Text] [Related]
7. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.
Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
9. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
[TBL] [Abstract][Full Text] [Related]
10. Activation of soluble guanylyl cyclase inhibits estradiol production and cyclic AMP accumulation from cultured rat granulosa cells.
Tafoya MA; Chen JY; Stewart RL; Lapolt PS
Fertil Steril; 2004 Oct; 82 Suppl 3():1154-9. PubMed ID: 15474089
[TBL] [Abstract][Full Text] [Related]
11. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of soluble guanylyl cyclase expression by cyclic AMP is mediated by mRNA-stabilizing protein HuR.
Klöss S; Srivastava R; Mülsch A
Mol Pharmacol; 2004 Jun; 65(6):1440-51. PubMed ID: 15155837
[TBL] [Abstract][Full Text] [Related]
13. Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels.
Ferrero R; Torres M
BMC Biochem; 2002 Sep; 3():26. PubMed ID: 12350235
[TBL] [Abstract][Full Text] [Related]
14. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
Takata M; Filippov G; Liu H; Ichinose F; Janssens S; Bloch DB; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L272-8. PubMed ID: 11159006
[TBL] [Abstract][Full Text] [Related]
15. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
16. Altered activities of cyclic nucleotide phosphodiesterases and soluble guanylyl cyclase in cultured RFL-6 cells.
Kraft PJ; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Qiu Y
Int J Biochem Cell Biol; 2004 Oct; 36(10):2086-95. PubMed ID: 15203121
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells.
Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylate cyclase-dependent relaxation is reduced in the adult rat bronchial smooth muscle.
Belik J; Hehne N; Pan J; Behrends S
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L699-703. PubMed ID: 17114282
[TBL] [Abstract][Full Text] [Related]
20. cAMP regulates soluble guanylate cyclase beta 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts.
Shimouchi A; Janssens SP; Bloch DB; Zapol WM; Bloch KD
Am J Physiol; 1993 Nov; 265(5 Pt 1):L456-61. PubMed ID: 7694505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
